Literature DB >> 9330597

Insulin-like growth factor-I stimulates myofibrillar genes and modulates atrial natriuretic factor mRNA in rat heart.

M Y Donath1, M A Gosteli-Peter, C Hauri, E R Froesch, J Zapf.   

Abstract

We have investigated the effect of a 6-day infusion of recombinant human (rh) IGF-I (0.3-1.0 mg/day) or rhGH (200 mU/day) into normal and hypophysectomized rats on the ventricular expression of myofibrillar genes (alpha- and beta-myosin heavy chain (MHC), skeletal and cardiac alpha-actin) and of atrial natriuretic factor (ANF). In normal rats, beta-MHC was not detectable either before or after IGF-I or GH, but alpha-MHC mRNA increased significantly (twofold) with GH (not statistically significant for IGF-I). In contrast to normal rats, hypophysectomized rats did not express alpha-MHC either before or after IGF-I or GH, but beta-MHC was strongly expressed and significantly stimulated (1.8-fold) by IGF-I (not statistically significantly with GH). Skeletal alpha-actin expression remained unchanged during IGF-I or GH treatment of normal rats, but was enhanced by both IGF-I and GH (2.5- and 2.8-fold respectively) in hypophysectomized rats. Expression of cardiac alpha-actin in normal and hypophysectomized rats was not altered by either treatment. IGF-I and GH decreased ventricular expression of ANF in normal rats by 63% and 45% respectively, but did not influence ANF expression in hypophysectomized rats. Our results show that IGF-I and GH (possibly via IGF-I) stimulate expression of myofibrillar genes and modulate ANF mRNA concentrations in rat heart ventricles in vivo, depending on the hormonal status of the animals. However, neither IGF-I nor GH caused a shift from the beta- to the alpha-MHC isoform in hypophysectomized rats.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9330597     DOI: 10.1530/eje.0.1370309

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

1.  The conserved phosphoinositide 3-kinase pathway determines heart size in mice.

Authors:  T Shioi; P M Kang; P S Douglas; J Hampe; C M Yballe; J Lawitts; L C Cantley; S Izumo
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  PKC alpha-dependent regulation of the IGF1 receptor in adult and embryonic rat cardiomyocytes.

Authors:  Ruchita Maniar; Anna Pecherskaya; Richard Ila; Michele Solem
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

3.  Clinical evidence of growth hormone for patients undergoing abdominal surgery: meta-analysis of randomized controlled trials.

Authors:  Yong Zhou; Xiao-Ting Wu; Gang Yang; Wen Zhuang; Mao-Ling Wei
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

Review 4.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

Review 5.  Insulin-like growth factor I: an attractive option for chronic heart failure?

Authors:  M Y Donath; J Zapf
Journal:  Drugs Aging       Date:  1999-10       Impact factor: 3.923

Review 6.  Myxomatous mitral valve disease in dogs: does size matter?

Authors:  Heidi G Parker; Paul Kilroy-Glynn
Journal:  J Vet Cardiol       Date:  2012-02-20       Impact factor: 1.701

Review 7.  Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure.

Authors:  Mahesh P Gupta
Journal:  J Mol Cell Cardiol       Date:  2007-07-21       Impact factor: 5.000

8.  ANP expression in the hypertensive heart.

Authors:  Gania Kessler-Icekson; Yael Barhum; Jutta Schaper; Wolfgang Schaper; Ella Kaganovsky; Thomas Brand
Journal:  Exp Clin Cardiol       Date:  2002

Review 9.  Pathogenesis and prevalence of hypertension in acromegaly.

Authors:  M Bondanelli; M R Ambrosio; E C degli Uberti
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

Review 10.  Cardiovascular effects of growth hormone.

Authors:  W J Brickman; B L Silverman
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.